Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Melflufen for Elderly Myeloma Patients in Second or Subsequent Relapse

NCT06682637 is registered in ClinicalTrials.gov with Fondazione EMN Italy Onlus as lead sponsor.

NCT NCT06682637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06682637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Melflufen for Elderly Myeloma Patients in Second or Subsequent Relapse
Lead sponsor
Fondazione EMN Italy Onlus
Phase
Phase 2
Overall status
Withdrawn
Start date
March 26, 2025
Completion date
March 26, 2025
Enrollment
0 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

relapse multiple myeloma